Related Articles
A single cycle of treatment with temozolomide, alone or combined with O6-benzylguanine, induces strong chemoresistance in melanoma cell clones in vitro: role of O6-methylguanine-DNA methyltransferase and the mismatch repair system
Oncolytic adenovirus-expressed RNA interference of O6‑methylguanine DNA methyltransferase activity may enhance the antitumor effects of temozolomide
PARP‑1 inhibition sensitizes temozolomide‑treated glioblastoma cell lines and decreases drug resistance independent of MGMT activity and PTEN proficiency
Interferon-β sensitizes human malignant melanoma cells to temozolomide-induced apoptosis and autophagy
Leukemia cells are sensitized to temozolomide, carmustine and melphalan by the inhibition of O6‑methylguanine‑DNA methyltransferase